Form 4: SI-BONE Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
SI-BONE Director Jeffrey W. Dunn executed pre-planned stock option exercises and subsequent sales of common stock on November 11, 2025.
Summary
- Jeffrey W. Dunn, a Director of SI-BONE, Inc. (SIBN), reported transactions on November 11, 2025.
- The transactions included the exercise of stock options to acquire 23,148 shares of common stock at an exercise price of $4.32 per share.
- Additionally, 56,852 shares of common stock were acquired through the exercise of stock options at an exercise price of $4.32 per share.
- A total of 23,148 shares of common stock were sold at a price of $18.95 per share.
- Another 56,852 shares of common stock were sold at a price of $18.95 per share.
- All sales were conducted pursuant to a Rule 10b5-1 trading plan established on May 7, 2025.
- Following these transactions, Mr. Dunn directly owns 10,307 shares of common stock, which includes shares issuable upon settlement of restricted stock units.
- An additional 118,874 shares are indirectly owned by The Jeffrey W. Dunn Living Trust dated May 17, 2012.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While a director selling shares can sometimes be viewed negatively, the transactions were pre-planned under a 10b5-1 plan, which mitigates concerns about reactive selling. The exercise of options is a positive event for the insider.
Positives
- The director exercised stock options at a significantly lower price ($4.32) than the sale price ($18.95), indicating a profitable transaction for the director.
- The transactions were executed under a pre-established Rule 10b5-1 trading plan, which suggests a planned and not reactive sale.
Negatives
- A director selling a substantial number of shares (80,000 shares total) could be perceived by some investors as a potential signal of reduced confidence, despite being pre-planned.
Future Outlook
NA
Industry Context
This filing reports an insider transaction, which is a routine disclosure for publicly traded companies. It does not provide information on broader industry trends or competitive landscape.
Related Party Transactions
- Shares are held indirectly by The Jeffrey W. Dunn Living Trust Dated May 17, 2012, which is a related party to the reporting person.
Stakeholder Impact
- Shareholders may note the director's sale of shares, which could be interpreted in various ways depending on individual investment strategies and market sentiment, despite the 10b5-1 plan.
Key Dates
| Date | Description |
|---|---|
| 2012-05-17 | Date of The Jeffrey W. Dunn Living Trust. |
| 2025-05-07 | Date the 10b5-1 trading plan was established. |
| 2025-11-11 | Date of the reported stock option exercises and common stock sales. |
| 2025-11-13 | Date the Form 4 was signed by the attorney-in-fact. |
| 2026-07-26 | Expiration date for the exercised stock options. |
Keywords
SI-BONE, SIBN, Form 4, Insider Trading, Stock Options, 10b5-1 Plan, Director Transactions, Equity Sales
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.